FDA Extends Review for Salix Diarrhea Drug
May 1, 2012
The Food and Drug Administration has extended by three months the review date for an experimental pill to treat HIV treatment-related diarrhea, according to Salix Pharmaceuticals, the drug's maker. FDA had been scheduled to review the drug, crofelemer, on June 5. Salix said in a statement that FDA said it needs more time for a full review, although it did not ask for any additional studies.
04.30.2012; Balaji Sridharan
Discontinuing Antibiotic Used to Prevent Opportunistic Infections Among HIV Patients Could Increase Risk of Malaria, Diarrhea
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)